Quantcast
Last updated on April 18, 2014 at 15:51 EDT

Latest Brain tumor Stories

2013-12-10 23:33:21

In response to an article published by Science Daily, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses the results of an immune system study that could lead to the cure of a hostile malignant brain tumor. New York, NY (PRWEB) December 10, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research, responds to an article published by Science Daily on November 25th, which discusses the results generated from...

2013-12-10 23:03:10

CareLine Provides Connections to Vital Resources for Caregivers Chicago, IL (PRWEB) December 10, 2013 Caring for a loved one with a brain tumor can be overwhelming, and the holiday season often leads to increased stress as families struggle to make life feel as normal as possible. For caregivers looking to better understand and manage the many challenges that arise during the holidays, the American Brain Tumor Association’s CareLine offers education and counseling by licensed oncology...

2013-12-10 08:30:37

Analysis Process Under Way For Data Monitoring Committee's Assessment BETHESDA, Md., Dec. 10, 2013 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the number of events required to trigger the first interim analysis of its Phase III clinical trial in patients with Glioblastoma multiforme (GBM) brain cancer has been reached, and the...

2013-12-09 14:05:31

Researchers identify mechanism implicated in brain cancer and a drug that decreases brain tumor growth Researchers at the University of Calgary's Hotchkiss Brain Institute (HBI) have made a discovery that could lead to better treatment for patients suffering from brain cancer. Despite current treatment strategies, the median survival for patients with the most aggressive brain cancer – called glioblastoma, is 15 months. Less than five per cent of patients survive beyond five years....

2013-12-09 12:26:38

DETROIT, Dec. 9, 2013 /PRNewswire/ -- Surgeons at Henry Ford Hospital have performed the first two minimally invasive laser brain surgeries in Michigan - one for epilepsy and one to treat a brain tumor. And in both cases the patients went home the day after the procedure. "These types of surgeries can be as effective as conventional brain surgery for select patients and certain tumors, with much less risk and side effects to the patient," says Steven Kalkanis, M.D., a neurosurgeon...

2013-12-09 10:00:24

PKM2 controls mitosis, saving cancer cells from death and promoting brain tumor growth Researchers have caught a protein they previously implicated in a variety of cancer-promoting roles performing a vital function in cell division, survival and development of brain tumors. In a paper published in Molecular Cell, Zhimin Lu, Ph.D., professor of Neuro-Oncology at The University of Texas MD Anderson Cancer Center and colleagues report how a tumor-specific protein flips a crucial switch in...

2013-12-09 08:28:49

Company invites individual and institutional investors to log-on to view presentation NEW YORK, Dec. 9, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI), developer of advanced cancer therapeutics, today announced that their December 5th RetailInvestorConferences.com presentation is now available for on-demand viewing. DelMar is developing VAL-083 in U.S. and China to treat aggressive cancers. DelMar's lead drug, VAL-083, is being developed in the U.S. to treat glioblastoma...

2013-12-06 23:04:34

This new partnership is unique opportunity for individuals interested in buying or selling their homes, to also give back Chris Elliott Fund and make a difference in a brain tumor patient's life. Redmond, WA (PRWEB) December 06, 2013 Coldwell Banker Bain real estate agent Anastasia Miles & Michele Schuler have formed a unique partnership with the Chris Elliott Fund, an organization providing brain tumor patient and family support nationwide. Each time a Chris Elliott Fund member,...

2013-12-06 11:13:12

Researchers describe a novel mechanism by which glioblastoma tumors resist targeted therapies A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which glioblastoma (GBM), the most common kind of brain cancer, evades targeted therapies. Published in the current issue of the journal Science, the paper describes how GBM tumor cells essentially hide the signaling molecule targeted by such therapies, adding a layer of complexity to current models of drug resistance in...

2013-12-06 11:11:38

Tumor cells temporarily lose mutation to evade drugs targeting mutation A team of scientists, led by principal investigator Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine, has found that brain cancer cells resist therapy by dialing down the gene mutation targeted by drugs, then re-amplify that growth-promoting mutation after therapy has stopped. The...